Have a feature idea you'd love to see implemented?
Let us know!
ACHV Achieve Life Sciences Inc.
Price (delayed)
$4.79
Market cap
$164.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.09
Enterprise value
$167.38M
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company
Highlights
Achieve Life Sciences's EPS has surged by 64% YoY and by 14% QoQ
ACHV's net income is up by 34% YoY
The quick ratio fell by 39% YoY but it rose by 38% QoQ
Achieve Life Sciences's equity has decreased by 14% QoQ
The debt has grown by 11% YoY and by 2.6% from the previous quarter
Key stats
What are the main financial stats of ACHV
Market
Valuations
Earnings
Shares outstanding
34.34M
Market cap
$164.49M
Enterprise value
$167.38M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.89
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$24.35M
EBITDA
-$24.13M
Free cash flow
-$19.72M
Per share
Balance sheet
Liquidity
EPS
-$1.09
Free cash flow per share
-$0.57
Book value per share
$1.23
Revenue per share
$0
TBVPS
$1.83
Total assets
$64.79M
Total liabilities
$22.51M
Debt
$17.65M
Equity
$42.29M
Working capital
$48.82M
Debt to equity
0.42
Current ratio
4.56
Quick ratio
4.47
Net debt/EBITDA
-0.12
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-61.7%
Return on equity
-116.8%
Return on invested capital
-157.7%
Return on capital employed
-47.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ACHV stock price
How has the Achieve Life Sciences stock price performed over time
Intraday
-3.82%
1 week
-4.3%
1 month
4.13%
1 year
19.75%
YTD
16.26%
QTD
1.05%
Financial performance
How have Achieve Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.37M
Net income
-$27.54M
Gross margin
N/A
Net margin
N/A
Achieve Life Sciences's operating income has increased by 36% YoY but it has decreased by 2.9% QoQ
ACHV's net income is up by 34% YoY
Growth
What is Achieve Life Sciences's growth rate over time
Valuation
What is Achieve Life Sciences stock price valuation
P/E
N/A
P/B
3.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Achieve Life Sciences's EPS has surged by 64% YoY and by 14% QoQ
The P/B is 80% less than the 5-year quarterly average of 20.4
Achieve Life Sciences's equity has decreased by 14% QoQ
Efficiency
How efficient is Achieve Life Sciences business performance
Achieve Life Sciences's return on equity has surged by 86% YoY and by 34% QoQ
Achieve Life Sciences's return on invested capital has surged by 79% YoY and by 61% QoQ
ACHV's ROA has soared by 62% year-on-year and by 19% since the previous quarter
Dividends
What is ACHV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ACHV.
Financial health
How did Achieve Life Sciences financials performed over time
The total assets is 188% more than the total liabilities
The total assets has soared by 124% YoY but it has contracted by 7% from the previous quarter
ACHV's current ratio is down by 40% year-on-year but it is up by 39% since the previous quarter
The debt is 58% less than the equity
Achieve Life Sciences's debt to equity has plunged by 74% YoY but it has increased by 20% from the previous quarter
Achieve Life Sciences's equity has decreased by 14% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.